Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Alexander Egeberg; Joseph F Merola; Knut Schäkel; Luis Puig; Patrick D Mahar; Isabella Yali Wang; Imre Pavo; Christopher Schuster; Christopher E M Griffiths

doi:10.3389/fmed.2023.1171132

Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Alexander Egeberg, Joseph F Merola, Knut Schäkel, Luis Puig, Patrick D Mahar, Isabella Yali Wang, Imre Pavo, Christopher Schuster, Christopher E M Griffiths

Dermato- & Venerologisk Afd.

Abstract

[This corrects the article DOI: 10.3389/fmed.2022.1092688.].

Originalsprog	Engelsk
Artikelnummer	1171132
Tidsskrift	Frontiers in Medicine
Vol/bind	10
Sider (fra-til)	1171132
ISSN	2296-858X
DOI	https://doi.org/10.3389/fmed.2023.1171132
Status	Udgivet - 2023

Adgang til dokumentet

10.3389/fmed.2023.1171132

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{8dfe432fef3c4ca48c217fbf600870a6,

title = "Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes",

abstract = "[This corrects the article DOI: 10.3389/fmed.2022.1092688.].",

keywords = "ixekizumab, moderate-to-severe psoriasis, obesity, prediabetes, type 2 diabetes",

author = "Alexander Egeberg and Merola, {Joseph F} and Knut Sch{\"a}kel and Luis Puig and Mahar, {Patrick D} and Wang, {Isabella Yali} and Imre Pavo and Christopher Schuster and Griffiths, {Christopher E M}",

note = "Copyright {\textcopyright} 2023 Egeberg, Merola, Sch{\"a}kel, Puig, Mahar, Wang, Pavo, Schuster and Griffiths.",

year = "2023",

doi = "10.3389/fmed.2023.1171132",

language = "English",

volume = "10",

pages = "1171132",

journal = "Frontiers in Medicine",

issn = "2296-858X",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Corrigendum

T2 - Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

AU - Egeberg, Alexander

AU - Merola, Joseph F

AU - Schäkel, Knut

AU - Puig, Luis

AU - Mahar, Patrick D

AU - Wang, Isabella Yali

AU - Pavo, Imre

AU - Schuster, Christopher

AU - Griffiths, Christopher E M

PY - 2023

Y1 - 2023

N2 - [This corrects the article DOI: 10.3389/fmed.2022.1092688.].

AB - [This corrects the article DOI: 10.3389/fmed.2022.1092688.].

KW - ixekizumab

KW - moderate-to-severe psoriasis

KW - obesity

KW - prediabetes

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85150895514&partnerID=8YFLogxK

U2 - 10.3389/fmed.2023.1171132

DO - 10.3389/fmed.2023.1171132

M3 - Comment/debate

C2 - 36974067

SN - 2296-858X

VL - 10

SP - 1171132

JO - Frontiers in Medicine

JF - Frontiers in Medicine

M1 - 1171132

ER -

Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater